Should I buy Well Health stock in 2025?

Why trust HelloSafe?

At HelloSafe, our experts have been monitoring the performance of Well Health for over three years. Each month, hundreds of thousands of Canadians trust us to help make sense of market trends and identify the best investment opportunities. Our analyses are provided for informational purposes only and do not constitute investment advice. In line with our ethical charter, we have never been, and will never be, paid by Well Health.

What is Well Health?

How much is Well Health stock?

The price of Well Health stock is unchanged today. As of now, Well Health trades at C$3.96 per share, reflecting no movement in the last 24 hours and a decline of approximately 8.55% over the past week.

The company holds a market capitalization around C$1.00 billion with an average 3-month trading volume of about 1,007,000 shares. Its price-to-earnings (P/E) ratio is 30.46, and the company does not currently pay a dividend. The stock shows a beta of 1.45, indicating greater volatility than the overall market.

These dynamics may appeal to investors anticipating longer-term growth in Canada's digital healthcare sector, but caution is warranted given recent short-term downward trends.

Our full analysis on Well Health stock

Following a thorough review of Well Health Technologies Corp’s latest quarterly financials and a detailed assessment of the company’s share price trajectory over the last three years, our team has synthesized key data points—including quantitative financial metrics, evolving technical signals, peer benchmarking, and proprietary market analytics—to bring clarity to this dynamic Canadian technology name. Drawing from multiple sources and advanced analytical models, this report positions Well Health within the broader digital healthcare sector and questions: Given the confluence of strong growth drivers and a recent technical pullback, could Well Health stock be poised to reemerge as a strategic entry point into healthcare technology for Canadian investors in 2025?

Recent Performance and Market Context

The past year has painted an intriguing picture for Well Health's share price. As of May 2025, Well Health trades at C$3.96, with a market capitalization of C$1.00 billion on the Toronto Stock Exchange. After a peak above C$7.30 in the last twelve months, the stock has corrected to current levels, now sitting close to its 52-week low of C$3.56. The one-year return remains positive at +9.70%, despite a recent pullback of roughly -9.8% over the last six months and -8.6% on the week—movements that coincide with market-wide volatility and sector-specific adjustments.

Crucially, this decline has not occurred in isolation. Well Health’s recent Q4 and full-year 2024 financial results reveal impressive momentum: annual revenue grew 19% to $919.7 million, and adjusted EBITDA expanded notably, despite the temporary deferral of $56.6 million in revenue at Circle Medical. The company also delivered 5.7 million patient engagements, up an exceptional 32% year-over-year—a testament to product-market fit and the company’s scaling abilities.

Sector-wide, digital healthcare continues to benefit from secular trends: ongoing public healthcare digitization, increasing telehealth adoption post-pandemic, and a growing emphasis on data-driven outcomes. In Canada, policy support and rising “buy Canadian” sentiment provide a macroeconomic tailwind. Against this backdrop, Well Health’s ambitious expansion and consolidation strategy aligns with a sector where scale and innovation are crucial.

Technical Analysis

From a technical perspective, Well Health sits at a potential inflection point. As of early May 2025, all major moving averages (20, 50, 100, 200-day EMAs) are above the current share price, reflecting a well-defined bearish trend in the short term. The 14-day RSI stands at 38.21, navigating the low-neutral zone and trending toward oversold territory—a level often watched by technical traders for possible reversals.

• MACD readings (-0.25) signal potential for further short-term downside, but the Williams %R at -60.00 has flashed a preliminary “buy” signal, while ADX (48.51) confirms strong trend strength—factors that can sometimes precede sharp reversals, especially in high-beta stocks like Well Health (1.45).
• Support levels are clustered in the C$3.81–C$3.91 range, while resistance looms at C$4.01–C$4.11.
• Notably, trading volume has remained resilient (average >1 million shares daily), even as price action has softened—a classic precursor to technical base building.

For investors attuned to technical entry points, the convergence of these signals—current proximity to oversold, support, and significant ADX reading—suggest the stock may be establishing a foundation, potentially ahead of its next operational or financial catalyst.

Fundamental Analysis

Beneath recent price volatility, Well Health’s fundamentals remain robust. Fiscal 2024 delivered a record $919.7 million in revenue (+19% YoY), driven by strong organic growth (20% in Canada) and continued integration of strategic acquisitions that now extend the company’s reach to 11 jurisdictions globally.

• Earnings Growth: Net income rose sharply to $29.1 million in 2024 (+74.9%), and free cash flow available to shareholders increased by a solid 16.3% to $49.3 million, further validating the company’s operating discipline.
• Forward Guidance: Management’s 2025 forecasts (revenue of $1.40–$1.45 billion, EBITDA of $190–$210 million) incorporate the expected recognition of deferred Circle Medical revenue and the full-year consolidation of HEALWELL. This sets up an appealing earnings acceleration profile and justifies forward-looking optimism.
• Valuation: At a trailing P/E of 30.5, price-to-sales of 1.1, and enterprise value/EBITDA of 11.1, Well Health trades at a significant discount to many fast-growing technology and healthcare peers—a valuation renewal that often precedes sector re-rates once confidence in forward estimates stabilizes.
• Strategic Advantages: The business is diversified, spanning EMRs, clinics, telehealth platforms, and advanced AI-powered solutions. Leadership’s disciplined capital allocation is highlighted by a string of successful acquisitions (including HEALWELL/Orion Health and Jack Nathan Health assets), scaling both product and geographic reach.
• Structural Innovation: The recent focus on in-house AI augmentation (WELL AI Voice), expanded billing/revenue cycle solutions, and new branding initiatives fortify the company’s competitive moat.

Well Health’s fundamental positioning thus remains materially stronger than share price trends alone might suggest, supporting a return of investor interest as the sector regains momentum.

Volume and Liquidity

Sustained trading activity is not only a sign of market confidence—it can underpin dynamic valuation re-rating. Well Health’s recent daily average turnover above one million shares demonstrates ample liquidity and robust institutional engagement—critical for investors seeking flexibility in timing entries and exits.

The company’s C$1 billion float, distributed among sophisticated and retail holders, has enabled the stock to weather profit-taking and sector rotations without undue illiquidity or gapping risk. As a result, Well Health remains a compelling vehicle for both active traders and longer-term investors who value liquidity alongside growth.

Catalysts and Positive Outlook

Looking forward, several tangible growth catalysts bolster the company’s investment narrative:

• Deferred Revenue Realization: The expected recognition of $56.6 million in Circle Medical revenue in 2025 represents a clear non-organic earnings boost, likely resulting in positive earnings surprises.
• HEALWELL & Orion Health Integration: The 69% voting interest in HEALWELL AI, alongside Orion Health’s integration, expands Well Health's international footprint and tech stack, creating new revenue synergies and cross-marketing opportunities.
• Continued Acquisition Program: With seven accretive acquisitions completed in just two months (adding $100 million in annualized revenue), Well Health’s buy-and-build model appears far from exhausted.
• ESG and “Buy Canadian” Alignment: Growing preference for locally governed, tech-forward healthcare providers in Canada positions the company for further public and institutional contract wins.
• AI-Driven Operational Efficiency: Leadership’s clear strategic pivot toward AI-powered virtual clinics, administrative technologies, and patient engagement solutions enhances scalability and cost advantage—creating a path toward sustainable margin expansion.

Sectorally, Well Health is benefiting from macro trends: digitization of health records, rising telehealth penetration, and demand for patient-centric, technology-augmented care. Regulatory support for digital health integration—particularly in Canada—offers an extra layer of stability, limiting downside legal risk.

Investment Strategies

For investors evaluating timing and positioning, several scenarios stand out as constructive:

• Short-Term (Swing Trading):
• With the stock nearing prior technical support (C$3.81–C$3.91) and RSI approaching oversold, tactical entries targeting a bounce to first resistance (C$4.01–C$4.11) may be attractive.
• Entry on confirmation of a price reversal or high-volume move above the 20-day EMA could add validation.
• Medium-Term (6–18 months):
• Over this period, the recognition of deferred revenue, ongoing acquisition integrations, and likely stabilization of revenue reporting set up positive earnings momentum. As the technical trend improves, a move toward the C$5–C$6 level is plausible, particularly if Q2–Q3 2025 results materially outperform revised guidance.
• Long-Term (2+ years):
• For patient, fundamentals-focused investors, Well Health’s diversified business, accelerating free cash flow, and discounted valuation relative to 2022 highs provide a compelling base case. As margin expansion and new-market synergies materialize, the potential for a sustained re-rating toward—and possibly above—the current analyst target of C$7.65 becomes increasingly realistic.

In all scenarios, the convergence of robust fundamentals with technical stabilization could offer optimal positioning well ahead of the next wave of sector or company-specific catalysts.

Is It the Right Time to Buy Well Health?

In summary, Well Health Technologies stands at the confluence of steady operational execution, transformative strategic moves, and technical market dislocation. The pullback to near-term support has realigned expectations and sharply improved entry-level risk/reward. The company’s long-term revenue growth, free cash flow generation, and commitment to product innovation—underpinned by a management team with a proven acquisition and integration track record—underscore its leadership within the digital healthcare landscape.

Despite recent technical weakness, the underlying case for Well Health is robust and gaining momentum. The sharp discrepancy between the current share price and both fundamental value and analyst consensus (with upside potential approaching 93%) furthers the view that the stock may be entering a new bullish phase. For Canadian investors searching for exposure to secular healthcare innovation, Well Health’s current valuations, future growth trajectory, and market liquidity appear to justify renewed portfolio consideration.

As digital healthcare continues to expand its role in the global innovation ecosystem, Well Health Technologies seems remarkably well-positioned for those willing to look beyond today’s volatility and focus on tomorrow’s opportunities. For investors attuned to growth, operational excellence, and emerging sector winners, Well Health now seems to represent an excellent opportunity at a potentially pivotal market juncture.

How to buy Well Health stock in Canada?

Buying shares of Well Health Technologies Corp (TSX: WELL) online is straightforward and secure when you use a regulated Canadian broker. You can choose between two main methods: buying shares outright (“spot” or cash buying), making you a direct shareholder, or speculating on price movements with Contracts for Difference (CFDs), which offer leverage and flexibility. Each method suits different investing objectives and risk profiles. Below, we explore both approaches and include practical examples to help you get started. To find the best rates and conditions, check our broker comparison further down the page.

Spot Buying

When you buy Well Health stock “for cash,” you become a direct shareholder in the company. This involves purchasing shares outright on the Toronto Stock Exchange (TSX) using Canadian dollars. Most Canadian brokers charge a flat commission per transaction, often between C$5 and C$10.

Practical Example: Spot Buying

Example: Suppose Well Health shares are trading at C$3.96 each and your broker charges a C$5 commission. With a C$1,000 investment:
- Commission: C$5
- Amount available to invest: C$995
- Number of shares you can buy: C$995 ÷ C$3.96 ≈ 251 shares

✔️ Gain Scenario: If the share price rises by 10% to C$4.36, your shares become worth 251 × C$4.36 = C$1,094.36.
Result: +C$99.36 gross gain (approximately +10% on your investment, before tax).

Trading via CFD

CFDs (Contracts for Difference) let you profit from Well Health’s price movements without owning the underlying shares. You can trade both rising and falling markets and apply leverage to multiply your exposure. CFD trading involves paying a spread (the difference between buy and sell prices) and, for positions held overnight, a daily financing fee.

Practical Example: CFD Trading

Example: With a C$1,000 margin and 5x leverage, your market exposure is C$5,000.
If Well Health’s share price rises by 8%, your CFD position gains 8% × 5 = 40%.
Result: +C$400 gain on a C$1,000 investment (excluding fees; cost to open and overnight fees would be deducted from profit).

Final Advice

Before investing, always compare the fees, available features, and support from different regulated Canadian brokers. Your choice should reflect your financial goals, risk comfort, and preferred investment style. If you prioritize long-term ownership, spot purchases offer direct security. For more active or short-term trading, CFDs provide flexibility and leverage. Explore our broker comparison below to identify providers that best fit your needs.

Platforms

Minimum Deposit

Discover

#1

Tier 1 regulation, including ASIC and FSA

#1

Star Trader

4.9

Minimum Deposit

$50

Discover

with our partner Star Trader

#2

Broker specializing in Forex and CFDs

#2

IFC Markets

4.8

Minimum Deposit

$1

Discover

with our partner IFC Markets

#3

Broker regulated since 2006

#3

Avatrade

4.8

Minimum Deposit

$100

Discover

with our partner Avatrade

Our 7 tips for buying Well Health stock

The latest news about Well Health

Well Health announced strong 2024 financial results, reporting a 19% revenue increase and 75% higher net income year-over-year. The company’s Canadian business generated 30% revenue growth and 22% growth in adjusted EBITDA, underlining robust momentum in its most important market. Despite temporary headwinds such as revenue deferrals at Circle Medical and a one-time revenue reduction at CRH due to the Change Healthcare cyberattack, the core performance highlights positive fundamentals and improving profitability, particularly in Canada.

Analyst consensus remains a Strong Buy with a consensus target price of C$7.65, almost doubling the current price. This reflects sustained optimism from market experts about Well Health's earnings trajectory and growth potential, especially considering anticipated revenue recognition from deferred segments in 2025 and the ongoing expansion of its Canadian operations. The wide spread between current trading levels and consensus forecasts offers a constructive signal for long-term investors monitoring Canadian healthcare equities.

The strategic move to exercise a call option for a controlling interest in HEALWELL AI and participate in the Orion Health acquisition broadens Well Health’s technology footprint and global presence. Through these recent transactions, Well Health significantly strengthened its AI, data analytics, and interoperability capabilities within its core Canadian market and internationally. This expansion, combined with a push to rebrand the provider solutions division as WELLSTAR Technologies—fuelled by significant private equity backing—reaffirms the company’s role as a leading innovator in healthcare technology across Canada.

Well Health has demonstrated strong operational execution in Canada, delivering a 32% year-over-year increase in patient visits and 20% organic growth for its Canadian business in 2024. The company’s acquisition of Jack Nathan Health’s clinical assets further consolidated its national clinic network, spanning 13 owned and operated clinics and 59 licensee clinics, expanding physical and virtual care delivery options for Canadian residents and reinforcing its leadership in digitized primary care.

Well Health set a 2025 revenue guidance of $1.4–1.45 billion and adjusted EBITDA of $190–210 million, including the benefit of deferred revenue recognition and full HEALWELL consolidation. This outlook, shared within the last week, supports medium-term momentum and underscores management’s confidence in continued expansion—particularly in the Canadian market, which remains buoyed by a growing “buy Canadian” preference among public sector clients and ongoing investments in digital and AI-powered healthcare solutions.

FAQ

P. Laurore

Finance expert

Co-founder of HelloSafe and holder of a Master's degree in finance, Pauline has recognised expertise in personal finance, which she uses to help users better understand and optimise their financial choices. At HelloSafe, Pauline plays a key role in designing clear, educational content on savings, investments and personal finance. Passionate about financial education, Pauline strives, with every piece of content she oversees, to provide reliable, transparent and unbiased information for independent and informed financial management. To this end, she has tested over 100 trading platforms to help internet users make the right choices.